Busulfan Sample Collection Study
Recruiting
- Conditions
- Subjects Treated With Busulfan
- First Posted Date
- 2023-02-03
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Saladax Biomedical, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT05711732
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, United States
🇺🇸The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Clozapine Therapy Sample Collection - Method Comparison Study
Completed
- Conditions
- Patients Prescribed Clozapine
- Interventions
- Device: MyCare Insite Clozapine Test
- First Posted Date
- 2022-06-16
- Last Posted Date
- 2023-05-18
- Lead Sponsor
- Saladax Biomedical, Inc.
- Target Recruit Count
- 153
- Registration Number
- NCT05422131
- Locations
- 🇺🇸
Saladax Biomedical, Inc., Bethlehem, Pennsylvania, United States
Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients
- First Posted Date
- 2015-03-03
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- Saladax Biomedical, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT02376296
- Locations
- 🇺🇸
UPMC CancerCenter - Beaver, Beaver, Pennsylvania, United States
🇺🇸UPMC CancerCenter - Upper St. Clair, Bethel Park, Pennsylvania, United States
🇺🇸UPMC CancerCenter - Horizon, Farrell, Pennsylvania, United States
Retrospective Evaluation of 5-FU Exposure Optimization in CRC Patients
Completed
- Conditions
- Adjuvant Colorectal CancerMetastatic Colorectal Cancer5-FU Containing Therapy Regimens
- First Posted Date
- 2014-02-05
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- Saladax Biomedical, Inc.
- Target Recruit Count
- 146
- Registration Number
- NCT02055560
- Locations
- 🇺🇸
University of California San Diego, La Jolla, California, United States
🇺🇸Hematology/Oncology of the North Shore, Skokie, Illinois, United States
🇺🇸Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
© Copyright 2025. All Rights Reserved by MedPath